**Core Concept**
Anemia of chronic disease, also known as anemia of inflammation, is a condition where the body's production of red blood cells is impaired due to chronic inflammation. This type of anemia is commonly seen in patients with chronic infections, autoimmune disorders, or malignancies.

**Why the Correct Answer is Right**
In anemia of chronic disease, the body's inflammatory response leads to the production of hepcidin, a hormone that regulates iron metabolism. Hepcidin binds to ferroportin, the only known iron exporter, and causes its internalization and degradation, resulting in reduced iron availability for erythropoiesis. Additionally, the inflammation also leads to increased production of interleukin-6 (IL-6), which stimulates the production of hepcidin. This results in a decrease in serum iron levels, which is a characteristic feature of anemia of chronic disease.

**Why Each Wrong Option is Incorrect**
* **Option A:** Anemia of chronic disease is not typically characterized by a decrease in red blood cell production, but rather a decrease in red blood cell lifespan and a decrease in serum iron levels.
* **Option B:** Anemia of chronic disease is not primarily caused by a deficiency in vitamin B12 or folate, but rather by the body's inflammatory response.
* **Option C:** Anemia of chronic disease is not typically characterized by an increase in serum iron levels, but rather a decrease due to the action of hepcidin.

**Clinical Pearl / High-Yield Fact**
Anemia of chronic disease should be distinguished from iron deficiency anemia, as the two conditions have distinct underlying pathophysiology and require different treatment approaches.

**Correct Answer:** D.